| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 119.673 | 201.608 | 180.603 | 155.054 | 151.536 | 44.260 | 61.910 | 106.943 | 131.724 | 123.131 |
| Total Income - EUR | 119.673 | 201.693 | 180.757 | 155.333 | 151.536 | 44.728 | 62.018 | 106.943 | 131.724 | 123.183 |
| Total Expenses - EUR | 111.219 | 198.817 | 176.229 | 163.655 | 144.270 | 48.165 | 62.609 | 97.850 | 133.454 | 124.364 |
| Gross Profit/Loss - EUR | 8.454 | 2.876 | 4.527 | -8.322 | 7.266 | -3.436 | -591 | 9.093 | -1.730 | -1.182 |
| Net Profit/Loss - EUR | 6.381 | 1.509 | 2.451 | -9.871 | 5.752 | -3.871 | -2.191 | 8.045 | -3.021 | -4.277 |
| Employees | 3 | 4 | 4 | 3 | 3 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Gamma Bio Prest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 335 | 823 | 570 | 324 | 9.687 | 7.209 | 4.787 | 2.501 | 199 | 8 |
| Current Assets | 13.783 | 10.108 | 14.996 | 8.393 | 9.152 | 6.816 | 9.473 | 13.736 | 27.212 | 21.341 |
| Inventories | 50 | 762 | 9.016 | 0 | 0 | 0 | 0 | 0 | 6.427 | 4.096 |
| Receivables | 13.625 | 5.629 | 4.628 | 8.129 | 7.632 | 6.311 | 7.244 | 9.137 | 11.870 | 14.688 |
| Cash | 107 | 3.718 | 1.352 | 264 | 1.519 | 504 | 2.229 | 4.599 | 8.916 | 2.556 |
| Shareholders Funds | 6.426 | 4.002 | 3.966 | -5.979 | -111 | -3.980 | -6.083 | 1.943 | -1.083 | -5.354 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.953 | 12.657 | 13.852 | 14.845 | 19.114 | 18.138 | 20.473 | 14.425 | 28.648 | 26.865 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4617 - 4617" | |||||||||
| CAEN Financial Year |
4617
|
|||||||||
Comments - Gamma Bio Prest Srl